Alder Biopharmaceutica Profile

USD 0.05  0.47%
10.3Last Month High 11.05 
10.58Trading Day  High 11.2 

Acquisition by Stephen Dow of 15000 shares of Alder Biopharmaceutica subject to Rule 16b-3

Alder Biopharmaceuticals Inc insider trading alert for grant of stock option (right to buy) by Stephen Dow, the corporate stakeholder, on November 12, 2017. This event was filed by Alder Biopharmaceuticals with SEC on 2017-05-26. Statement of changes in beneficial ownership - SEC Form 4. Stephen Dow is currently serves as independent chairman of the board of Alder Biopharmaceutica [view details]   

Alder Biopharmaceutica Summary

Alder Biopharmaceuticals Inc (ALDR) is traded on NASDAQ General Markets in USA. It is located in WASHINGTON, U.S.A and employs 113 people. Alder Biopharmaceutica is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 748.76 M. Alder Biopharmaceuticals Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 67.76 M outstanding shares of which 7.45 M shares are presently shorted by private and institutional investors with about 7.35 trading days to cover. Alder BioPharmace currently holds about 330.88 M in cash with (222.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.88.
Check Alder Biopharmaceutica Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Redmile Group LlcCommon Shares6.5 M79.3 M
Vanguard Group IncCommon Shares5 M61.6 M
View Alder Biopharmaceutica Diagnostics

Selected Alder Biopharmaceuticals Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Alder Biopharmaceutica Against Markets

Current Ratings  

Alder Biopharmaceutica 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
< 50% 
Alder BioPharmaceuticals, Inc., a clinicalstage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameAlder Biopharmaceuticals Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
Business Address11804 North Creek Parkway South, Bothell, WA 98011, United States
ExchangeNASDAQ General Markets
CIK Number01423824.0
Contact Number425 205 2900
CurrencyUSD - US Dollar


Alder Biopharmaceutica Analyst Recommendations
Target PriceAdvice# of Analysts
40.33Strong Buy6Odds
Alder Biopharmaceuticals Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Alder Biopharmaceutica Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Alder Biopharmaceutica Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.95April 27, 2017
Alder Biopharmaceuticals Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate